AKAAF yields 4.64% · JNJ yields 2.13%● Live data
📍 AKAAF pulled ahead of the other in Year 1
Combined, AKAAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AKAAF + JNJ for your $10,000?
Aker ASA operates as an industrial investment company in Norway, the European Union, North America, South America, Asia, and internationally. It operates in two segments, Industrial Holdings and Financial Investments. The company engages in the exploration and production of oil and gas; provides solutions, products, and services to the energy industry; develops and delivers technologies to drilling market; holds oil reserves; and harvests, develops, markets, and sells krill-based ingredients and product for nutraceutical, aquaculture, and animal feed applications. It also focuses on renewable energy and green technologies; builds and operates sea-based salmon farming; offers Cognite Data Fusion that collects, processes, and facilitates big data for its industry customers; designs, constructs, and leases vessels; owns and operates supply-vessels, anchor handling vessels, and construction service vessels; trades in financial instruments; operates platform for venture capital in industrial technology; develops real estate and software; acts as an investment manager; and invests in bitcoin, and projects and companies throughout the bitcoin ecosystem. The company was founded in 1841 and is based in Lysaker, Norway. Aker ASA is a subsidiary of TRG Holding AS.
Full AKAAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.